Lyra Therapeutics, Inc. — All Filings
369 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
REGDEX
REGDEX/A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-21-021186 | May 28, 2021 | May 26, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-021185 | May 28, 2021 | May 26, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-021184 | May 28, 2021 | May 26, 2021 |
| 8-K | 8-K | 0001564590-21-030615 | May 28, 2021 | May 26, 2021 |
| 424B5 | 424B5 | 0001193125-21-171195 | May 25, 2021 | — |
| EFFECT | — | 9999999995-21-002044 | May 20, 2021 | — |
| CORRESP | — | 0001193125-21-165300 | May 18, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-068157 | May 17, 2021 | — |
| UPLOAD | — | 0000000000-21-006192 | May 17, 2021 | — |
| S-3 | S-3 | 0001193125-21-157815 | May 11, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-026569 | May 11, 2021 | Mar 31, 2021 |
| 8-K | 8-K | 0001564590-21-026550 | May 11, 2021 | — |
| DEFA14A | DEFA14A | 0001564590-21-018769 | Apr 14, 2021 | — |
| DEF 14A | DEF 14A | 0001564590-21-018767 | Apr 14, 2021 | May 26, 2021 |
| 8-K | 8-K | 0001564590-21-018691 | Apr 13, 2021 | Apr 11, 2021 |
| 10-K | 10-K | 0001564590-21-011767 | Mar 9, 2021 | Dec 31, 2020 |
| 8-K | 8-K | 0001564590-21-011749 | Mar 9, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001104659-21-024230 | Feb 16, 2021 | — |
| SC 13G | SCHEDULE 13G HOLDINGS REPORT | 0001172661-21-000633 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-043442 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-041856 | Feb 12, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-041556 | Feb 12, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-005659 | Feb 10, 2021 | Feb 8, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-005656 | Feb 10, 2021 | Feb 8, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-005648 | Feb 10, 2021 | Feb 8, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-005650 | Feb 10, 2021 | Feb 8, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-005645 | Feb 10, 2021 | Feb 8, 2021 |
| SC 13G | SC 13G | 0001193125-20-329939 | Dec 30, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-034285 | Dec 17, 2020 | Dec 16, 2020 |
| 8-K/A | 8-K/A | 0001193125-20-314971 | Dec 10, 2020 | Oct 26, 2020 |
| 8-K | 8-K | 0001193125-20-311233 | Dec 7, 2020 | — |
| 10-Q | 10-Q | 0001564590-20-053016 | Nov 10, 2020 | Sep 30, 2020 |
| 8-K | 8-K | 0001564590-20-053015 | Nov 10, 2020 | — |
| 8-K | 8-K | 0001193125-20-282679 | Oct 30, 2020 | Oct 26, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-029782 | Oct 29, 2020 | Oct 27, 2020 |
| 3 | FORM 3 SUBMISSION | 0000899243-20-029768 | Oct 29, 2020 | Oct 27, 2020 |
| 10-Q | 10-Q | 0001564590-20-036803 | Aug 5, 2020 | Jun 30, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-021449 | Aug 5, 2020 | Aug 3, 2020 |
| 3 | FORM 3 SUBMISSION | 0000899243-20-021446 | Aug 5, 2020 | Aug 3, 2020 |
| 8-K | 8-K | 0001564590-20-036787 | Aug 5, 2020 | — |
| 8-K | 8-K | 0001193125-20-198571 | Jul 24, 2020 | Jul 20, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-017762 | Jun 26, 2020 | Jun 24, 2020 |
| 3 | FORM 3 SUBMISSION | 0000899243-20-017759 | Jun 26, 2020 | Jun 24, 2020 |
| SC 13D | SC 13D | 0001193125-20-157437 | Jun 1, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-014580 | May 29, 2020 | May 5, 2020 |
| 10-Q | 10-Q | 0001564590-20-027334 | May 28, 2020 | Mar 31, 2020 |
| 8-K | 8-K | 0001193125-20-154270 | May 28, 2020 | — |
| 4 | — | 0001493152-20-009217 | May 15, 2020 | May 5, 2020 |
| 3 | — | 0001493152-20-009215 | May 15, 2020 | Apr 30, 2020 |
| SC 13D | SC 13D | 0001193125-20-144122 | May 15, 2020 | — |